AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29986616 — intervention group
Group type: COMPARATOR
Intervention: Cumberland Ankle Instability Tool (CAIT)
Number of subjects: 120
Study 29986616 — intervention group
Group type: COMPARATOR
Intervention: Foot and Ankle Ability Measure
Number of subjects: 120
Study 29986616 — intervention group
Group type: COMPARATOR
Intervention: Foot and Ankle Outcome Score
Number of subjects: 120
Study 29986616 — intervention group
Group type: COMPARATOR
Intervention: Fear Avoidance Belief questionnaire
Number of subjects: 120
Study 29986616 — intervention group
Group type: COMPARATOR
Intervention: Tampa Scale of Kinesiophobia
Number of subjects: 120
Study 28910237 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (2 mg, subcutaneous injections, once weekly)
Number of subjects: 14752
Study 28910237 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo, once weekly)
Number of subjects: 14752
Study 28910237 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 14752
Study 28910237 — intervention group
Group type: COMPARATOR
Intervention: Exenatide and Placebo
Number of subjects: 14752
Study 24830782 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei ssp. paracasei F19 (LF19)
Number of subjects: 120
Study 24830782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 22342470 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized education workshops (3 workshops lasting 1.5 hours each) plus usual thermal therapy for 3 weeks
Number of subjects: 360
Study 22342470 — intervention group
Group type: COMPARATOR
Intervention: Usual thermal therapy and non‐standardized verbal information
Number of subjects: 360
Study 22342470 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 360
Study 22342470 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized education workshops
Number of subjects: 360
Study 21749263 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared-LED illumination during treadmill training
Number of subjects: 20
Study 21749263 — intervention group
Group type: COMPARATOR
Intervention: Control group (treadmill training only)
Number of subjects: 20
Study 19167522 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 121
Study 19167522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 16723323 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Department assessment of neuropsychological and balance deficits and pain severity in concussed individuals
Number of subjects: 29
Study 16723323 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Department assessment of concussed individuals
Number of subjects: 29
Study 16723323 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive impairment, pain, and balance deficits
Number of subjects: 29
Study 16723323 — intervention group
Group type: COMPARATOR
Intervention: Control group (minor orthopedic injuries and ED visitors)
Number of subjects: 29
Study 15112270 — intervention group
Group type: EXPERIMENTAL
Intervention: EBV CTL infusion (5.0 x 10(6) EBV CTL/kg per dose, 3 infusions)
Number of subjects: 6
Study 15112270 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine (30 mg/m(2) per day for 3 days) followed by a single CTL infusion (1.5 x 10(7) EBV CTL/kg)
Number of subjects: 6
Study 15112270 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine (30 mg/m(2) per day for 3 days)
Number of subjects: 6
Study 11330994 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 6473
Study 11330994 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 6473
Study 11330994 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 7 adolescents
Number of subjects: 6473
Study 11330994 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban and rural adolescents
Number of subjects: 6473
Study 9293727 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive strategy for early recognition and intervention
Number of subjects: 0
Study 9293727 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy and pharmacologic advances
Number of subjects: 0
Study 9293727 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer interventional measures
Number of subjects: 0
Study 7967426 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 250
Study 7967426 — intervention group
Group type: COMPARATOR
Intervention: Existing BMT protocols (Belgian, American, British)
Number of subjects: 250
Study 3665325 — intervention group
Group type: EXPERIMENTAL
Intervention: Theostat 300® with fasting
Number of subjects: 12
Study 3665325 — intervention group
Group type: EXPERIMENTAL
Intervention: Theostat 300® with low-fat breakfast (10 g)
Number of subjects: 12
Study 3665325 — intervention group
Group type: EXPERIMENTAL
Intervention: Theostat 300® with high-fat breakfast (60 g)
Number of subjects: 12
Study 3665325 — intervention group
Group type: COMPARATOR
Intervention: Control (fasting)
Number of subjects: 12
Study 30015793 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-NRTI regimen (abacavir/zidovudine/lamivudine)
Number of subjects: 197
Study 30015793 — intervention group
Group type: COMPARATOR
Intervention: Dual-NRTI + PI regimen (lopinavir/ritonavir/zidovudine/lamivudine)
Number of subjects: 197
Study 28297590 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention for older persons with schizophrenia (June 2008 to May 2014)
Number of subjects: 171
Study 28297590 — intervention group
Group type: COMPARATOR
Intervention: Diffusion tensor imaging and genetics study of psychosis across the life span (February 2007 to December 2013)
Number of subjects: 171
Study 26281825 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy for painful bone metastases
Number of subjects: 956
Study 23006823 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% Stannous fluoride (SnF(2))
Number of subjects: 16
Study 23006823 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% Titanium tetrafluoride (TiF(4))
Number of subjects: 16
Study 23006823 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Sodium fluoride (NaF)
Number of subjects: 16
Study 23006823 — intervention group
Group type: COMPARATOR
Intervention: Control (no fluoride treatment)
Number of subjects: 16
Study 21419321 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg of selenium as glycinate for 6 weeks
Number of subjects: 30
Study 21419321 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study 18207120 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral retinal laser ablation
Number of subjects: 5
Study 18207120 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 5
Study 18207120 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated avascular retina
Number of subjects: 5
Study 18207120 — intervention group
Group type: EXPERIMENTAL
Intervention: All 10 eyes
Number of subjects: 5
Study 16372389 — intervention group
Group type: EXPERIMENTAL
Intervention: van Elteren test
Number of subjects: 0
Study 16372389 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 14668778 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting perfusion defects (PDs)
Number of subjects: 139
Study 14668778 — intervention group
Group type: COMPARATOR
Intervention: Stress-induced perfusion defects (PDs)
Number of subjects: 139
Study 10620203 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA + BO
Number of subjects: 0
Study 10620203 — intervention group
Group type: COMPARATOR
Intervention: CsA + placebo
Number of subjects: 0
Study 10620203 — intervention group
Group type: COMPARATOR
Intervention: Single dose of BO
Number of subjects: 0
Study 8644056 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 8300
Study 8644056 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 8300
Study 1906718 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer liner and posterior composite resin
Number of subjects: 30
Study 1906718 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer silver cermet placed in the proximal box to the contact area and the remainder restored with posterior composite resin
Number of subjects: 30
Study 1906718 — intervention group
Group type: COMPARATOR
Intervention: Glass ionomer silver cermet only
Number of subjects: 30
Study 1906718 — intervention group
Group type: COMPARATOR
Intervention: All techniques (1, 2, and 3)
Number of subjects: 30
Study 6336863 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (oral or intravenous)
Number of subjects: 181
Study 6336863 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metronidazole administered 1 hour before and at 8 and 16 hours after the operation
Number of subjects: 181
Study 6336863 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin and neomycin as preoperative bowel preparations
Number of subjects: 181
Study 31778194 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperimmune anti-influenza plasma treatment in the FluPlasma trial
Number of subjects: 2000
Study 31778194 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered live-attenuated influenza vaccine in the SNIF trial
Number of subjects: 2000
Study 31778194 — intervention group
Group type: EXPERIMENTAL
Intervention: InFLUenza Patient-Reported Outcome (FLU-PRO) survey
Number of subjects: 2000
Study 31778194 — intervention group
Group type: EXPERIMENTAL
Intervention: Three types of licensed vaccines in the PAIVED study
Number of subjects: 2000
Study 31778194 — intervention group
Group type: EXPERIMENTAL
Intervention: Flu Breath Test (FBT) study
Number of subjects: 2000
Study 31778194 — intervention group
Group type: EXPERIMENTAL
Intervention: Study to Address Threats of ARI in Congregate Military Populations (ATARI)
Number of subjects: 2000
Study 29614719 — intervention group
Group type: EXPERIMENTAL
Intervention: Melon concentrate application and/or supplementation
Number of subjects: 0
Study 27165651 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based violence prevention programme involving teacher training in classroom behaviour management and strategies to promote children's social-emotional competence, delivered through five full-day workshops, monthly in-class coaching over 2 school terms, and weekly text messages.
Number of subjects: 912
Study 24465407 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment
Number of subjects: 66
Study 24465407 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) patients with MS
Number of subjects: 66
Study 24465407 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 66
Study 22317852 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose prednisone (1 mg × kg × day for 4 weeks, then reduced to 5mg every 2 weeks up to 10mg) combined with cyclophosphamide (monthly for 6 months, then twice-monthly for 6 months)
Number of subjects: 23
Study 22317852 — intervention group
Group type: COMPARATOR
Intervention: High dose prednisone (10mg daily) combined with cyclophosphamide (ev)
Number of subjects: 23
Study 22317852 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (low dose and high dose)
Number of subjects: 23
Study 20196964 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.6 g PUFA/day
Number of subjects: 60
Study 20196964 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 g PUFA/day
Number of subjects: 60
Study 20196964 — intervention group
Group type: COMPARATOR
Intervention: Control oil (olive oil)
Number of subjects: 60
Study 19000316 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine computerized HRQoL measurement
Number of subjects: 587
Study 19000316 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians' access to computerized HRQoL information
Number of subjects: 587
Study 16032936 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg/dose salbutamol (group 1)
Number of subjects: 20
Study 16032936 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lower‐dose salbutamol (0.10 mg/kg/dose) and ipratropium bromide (5 mcg/kg/dose) (group 2)
Number of subjects: 20
Study 12014521 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised training for 12 weeks
Number of subjects: 24
Study 12014521 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised training for 12 weeks
Number of subjects: 24
Study 12014521 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (both supervised and unsupervised)
Number of subjects: 24
Study 11072387 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking two cigarettes after nicotine deprivation
Number of subjects: 20
Study 11072387 — intervention group
Group type: COMPARATOR
Intervention: Tobacco deprivation
Number of subjects: 20
Study 8653220 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutaraldehyde-modified Dermatophagoides pteronyssinus extract
Number of subjects: 0
Study 8653220 — intervention group
Group type: COMPARATOR
Intervention: Unmodified Dermatophagoides pteronyssinus extract
Number of subjects: 0
Study 2219608 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol alone
Number of subjects: 87
Study 2219608 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol and thiazide
Number of subjects: 87
Study 69596 — intervention group
Group type: EXPERIMENTAL
Intervention: organo-heparinoid ointment (Hirudoid 40,000)
Number of subjects: 40
Study 69596 — intervention group
Group type: COMPARATOR
Intervention: placebo ointment
Number of subjects: 40
Study 31519795 — intervention group
Group type: COMPARATOR
Intervention: Pre-TPD compliance
Number of subjects: 107
Study 31519795 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-TPD compliance
Number of subjects: 107
Study 31519795 — intervention group
Group type: COMPARATOR
Intervention: Overall compliance pre-TPD
Number of subjects: 107
Study 31519795 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall compliance post-TPD
Number of subjects: 107
Study 31099214 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with cinesiotherapy cupping
Number of subjects: 78
Study 31099214 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture combined with conventional cupping
Number of subjects: 78
Study 28258819 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent health report intervention
Number of subjects: 128
Study 28258819 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 128
Study 23647357 — intervention group
Group type: EXPERIMENTAL
Intervention: High-leucine whey protein hydrolysate + carbohydrate (WHD)
Number of subjects: 22
Study 23647357 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (PLA)
Number of subjects: 22
Study 23838148 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous infusion of astragalosides injection (AI) at 200 ml
Number of subjects: 4
Study 23838148 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous infusion of astragalosides injection (AI) at 300 ml
Number of subjects: 4
Study 23838148 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous infusion of astragalosides injection (AI) at 400 ml
Number of subjects: 4
Study 23838148 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous infusion of astragalosides injection (AI) at 500 ml
Number of subjects: 4
Study 23838148 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated intravenous infusion of astragalosides injection (AI)
Number of subjects: 4
Study 23838148 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events after administration of AI
Number of subjects: 4
Study 20415992 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 13
Study 20415992 — intervention group
Group type: COMPARATOR
Intervention: Benzathine penicillin
Number of subjects: 13
Study 18715274 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 g/kg dose of alcohol
Number of subjects: 13
Study 18715274 — intervention group
Group type: COMPARATOR
Intervention: Control (no alcohol)
Number of subjects: 13
Study 16544086 — intervention group
Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES) applied to the submental muscles for ten 1‐h treatments over two weeks.
Number of subjects: 10
Study 16544086 — intervention group
Group type: COMPARATOR
Intervention: No treatment (A condition) during the control phase.
Number of subjects: 10
Study 12627929 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 70
Study 12627929 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus thalidomide
Number of subjects: 70
Study 11938810 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg of ligustrazine
Number of subjects: 69
Study 11938810 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg of ligustrazine
Number of subjects: 69
Study 11938810 — intervention group
Group type: EXPERIMENTAL
Intervention: 480 mg of ligustrazine
Number of subjects: 69
Study 1514168 — intervention group
Group type: EXPERIMENTAL
Intervention: GR32191 (40 mg) + heparin (5,000 IU bolus + 1,000 IU/h for 3 h)
Number of subjects: 18
Study 1514168 — intervention group
Group type: EXPERIMENTAL
Intervention: GR32191 (80 mg) + heparin (5,000 IU bolus + 1,000 IU/h for 3 h)
Number of subjects: 18
Study 1514168 — intervention group
Group type: EXPERIMENTAL
Intervention: GR32191 (40 mg) + placebo
Number of subjects: 18
Study 1514168 — intervention group
Group type: EXPERIMENTAL
Intervention: GR32191 (80 mg) + placebo
Number of subjects: 18
Study 1514168 — intervention group
Group type: COMPARATOR
Intervention: heparin + placebo
Number of subjects: 18
Study 6098035 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin-sulbactam regimen (aqueous procaine penicillin G, sulbactam, and probenecid)
Number of subjects: 193
Study 6098035 — intervention group
Group type: COMPARATOR
Intervention: Spectinomycin
Number of subjects: 193
Study 6098035 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin-sulbactam regimen
Number of subjects: 193
Study 31539833 — intervention group
Group type: EXPERIMENTAL
Intervention: Dampening instructions
Number of subjects: 89
Study 31539833 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplifying instructions
Number of subjects: 89
Study 31539833 — intervention group
Group type: COMPARATOR
Intervention: No instruction control
Number of subjects: 89
Study 29800212 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 848
Study 29800212 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 848
Study 26130292 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg/day for 6 weeks, then 10 mg/day for 18 weeks (total 24 weeks)
Number of subjects: 62
Study 26130292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 24471662 — intervention group
Group type: EXPERIMENTAL
Intervention: End-hole catheter
Number of subjects: 156
Study 24471662 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-hole catheter
Number of subjects: 156
Study 24471662 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-hole catheter
Number of subjects: 156
Study 22362830 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Mobile Treatment (BMT)
Number of subjects: 68
Study 22362830 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 68
Study 20100903 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus trimetazidine (TMZ)
Number of subjects: 30
Study 20100903 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone (Control)
Number of subjects: 30
Study 20100903 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus trimetazidine (TMZ) in ischemic patients
Number of subjects: 30
Study 18379485 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitemporal transcranial magnetic therapy
Number of subjects: 88
Study 16251627 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ferritin concentrations > 160 microg/L in women
Number of subjects: 10197
Study 16251627 — intervention group
Group type: COMPARATOR
Intervention: Baseline serum transferrin and serum ferritin concentrations
Number of subjects: 10197
Study 16251627 — intervention group
Group type: COMPARATOR
Intervention: Baseline serum ferritin and serum transferrin concentrations
Number of subjects: 10197
Study 16251627 — intervention group
Group type: COMPARATOR
Intervention: Dietary iron intake
Number of subjects: 10197
Study 11934682 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IGF-I therapy (40 microg.kg(‐1).day(‐1))
Number of subjects: 12
Study 9473015 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine 500 mg/day
Number of subjects: 154
Study 9473015 — intervention group
Group type: COMPARATOR
Intervention: No antiretroviral treatment
Number of subjects: 154
Study 8539088 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiar faces (congruent)
Number of subjects: 0
Study 8539088 — intervention group
Group type: COMPARATOR
Intervention: Unfamiliar faces (incongruent)
Number of subjects: 0
Study 1760362 — intervention group
Group type: EXPERIMENTAL
Intervention: UVA therapy
Number of subjects: 21
Study 1760362 — intervention group
Group type: COMPARATOR
Intervention: UVB therapy
Number of subjects: 21
Study 7053654 — intervention group
Group type: EXPERIMENTAL
Intervention: Hill antireflux procedure
Number of subjects: 391
Study 7053654 — intervention group
Group type: EXPERIMENTAL
Intervention: Belsey antireflux procedure
Number of subjects: 391
Study 7053654 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen antireflux procedure
Number of subjects: 391
Study 7053654 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 391
Study 31075056 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal surgery
Number of subjects: 156
Study 31075056 — intervention group
Group type: COMPARATOR
Intervention: Postnatal surgery
Number of subjects: 156
Study 26587725 — intervention group
Group type: EXPERIMENTAL
Intervention: Left circumflex (LCX) culprit
Number of subjects: 9406
Study 26587725 — intervention group
Group type: EXPERIMENTAL
Intervention: Right coronary artery (RCA) culprit
Number of subjects: 9406
Study 26587725 — intervention group
Group type: EXPERIMENTAL
Intervention: Left anterior descending (LAD) culprit
Number of subjects: 9406
Study 26587725 — intervention group
Group type: COMPARATOR
Intervention: Culprit artery (LCX, LAD, RCA)
Number of subjects: 9406
Study 24482383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 405
Study 24482383 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 405